Search for Clinical Trial Results

Sponsored By

Phosphorus Metabolism Disorders - 25 Studies Found

Status Study
Completed Study Name: Dietary Phosphate and Serum Phosphorus
Condition: Phosphorus Metabolism Disorders
Date: 2015-04-22
Not yet recruiting Study Name: The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis
Condition: Hyperphosphatemia
Date: 2017-05-21
Interventions:
  • Drug: Niacin tablets
Recruiting Study Name: Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices
Condition:
  • Renal Dialysis
  • Hyperphosphatemia
  • Dietary Modification

    • Date: 2017-04-04
    Interventions:
    • Other: Current Low Phosphorus Diet Prescription

Not yet recruiting Study Name: Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients
Condition: Hyperphosphatemia
Date: 2017-03-01
Interventions: Drug: Ferric Citrate One to two tablets of Ferric Citrate phosphorus binder administered by mouth before
Recruiting Study Name: Behavioral Management of Phosphorus in Hemodialysis Patients
Condition:
  • Cardiovascular Disease (CKD)
  • Hyperphosphatemia

Date: 2016-10-17
Interventions:
  • Behavioral: Education (Edu) Th
Recruiting Study Name: Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia
Condition: Hyperphosphatemia
Date: 2016-07-14
Interventions:
  • Drug: Nicotinic Acids Nicotini
Recruiting Study Name: An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia
Condition: Hyperphosphatemia
Date: 2016-02-17
Interventions:
  • Drug: PA21 (Velphoro®)

Recruiting Study Name: Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)
Condition: Hyperphosphatemia
Date: 2016-02-09
Interventions: Drug: sucroferric oxyhydroxide The non-interventional design allows the observation of patients in a bro
Completed Study Name: Dose Finding Study to Treat High Phosphate Levels in the Blood.
Condition: Hyperphosphatemia
Date: 2014-03-06
Interventions:
  • Drug: AZD1722 AZD1722, oral ta
Completed Study Name: The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients
Condition: Hyperphosphatemia
Date: 2013-05-04
Interventions: Drug: Mg Oxide 250 mg orally for 4 weeks Other Name:
Next >>>